## Pathophysiology of Acanthosis Nigricans **Key Point:** AN is driven by hyperinsulinemia and/or tumour-derived insulin-like growth factors (IGF), not by immune or melanocyte-destructive mechanisms. ### Primary Mechanism: IGF & Insulin Signalling ```mermaid flowchart TD A[Hyperinsulinemia or Tumour-derived IGF]:::outcome --> B[Binding to IGF-1 receptor on keratinocytes]:::action B --> C[Activation of MAPK & PI3K pathways]:::action C --> D[Epidermal hyperplasia & papillomatosis]:::outcome D --> E[Velvety, hyperpigmented skin]:::outcome A --> F[Increased melanin synthesis]:::action F --> E ``` **High-Yield:** The two main drivers are: 1. **Insulin resistance** (metabolic AN) — excess circulating insulin stimulates IGF-1 receptors on keratinocytes 2. **Paraneoplastic AN** — tumour cells (especially gastric cancer) secrete IGF-II, which acts systemically ### Histopathology | Feature | Mechanism | | --- | --- | | Acanthosis (epidermal thickening) | IGF-mediated keratinocyte proliferation | | Papillomatosis (ridge-like projections) | Exaggerated dermal-epidermal undulations | | Hyperpigmentation | Increased melanin in basal layer; melanin transfer to keratinocytes | | Hyperkeratosis | Increased keratin production | **Clinical Pearl:** AN improves with treatment of the underlying cause (weight loss in metabolic AN, tumour resection in paraneoplastic AN), confirming that IGF/insulin signalling is reversible. ### Why Other Mechanisms Are Wrong - ~~Direct tumour infiltration~~ would cause ulceration, not smooth papillomatosis - ~~Autoimmune melanocyte destruction~~ would cause depigmentation (vitiligo), not hyperpigmentation - ~~α-MSH~~ is elevated in some cases but is secondary to systemic inflammation, not the primary driver **Mnemonic:** **IGF-IN** = IGF drives epidermal growth → Insulin resistance or Neoplasm → Nodular/papillomatous appearance 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.